The Down Under medical landscape is abuzz with the emergence of retatrutide, a novel dual GIP and GLP-1 medication showing impressive results in early trials for managing obesity. This therapy promises https://veriea.com/2026/06/10/retatrutide-australia-the-next-generation-in-weight-loss/